Securities Registration: Employee Benefit Plan (s-8)
December 14 2018 - 4:51PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
S-8
REGISTRATION
STATEMENT
UNDER
THE SECURITIES
ACT OF 1933
MEDTAINER,
INC.
(Exact Name
of Registrant as Specified in Its Charter)
|
|
|
Florida
|
|
65-0207200
|
(State
or Other Jurisdiction of
Incorporation
or Organization)
|
|
(I.R.S.
Employer
Identification
No.)
|
Medtainer,
Inc.
1620 Commerce
St.
Corona,
California 92880
(844) 226-5649
(Address,
including zip code, and telephone number, including area code, of Registrant’s principal executive offices)
2018
Incentive Award Plan
(Full Title
of the Plans)
Curtis
Fairbrother
Chief Executive
Officer
Medtainer,
Inc.
1620 Commerce
St.
Corona,
California 92880
(844) 226-5649
(Name, address,
including zip code, and telephone number, including area code, of agent for service)
Copies
to:
Barry J.
Miller, Esq.
547 Merritt
Lane
Birmingham,
Michigan 48009
(248) 232-8039
bjmiller@bjmpllc.com
Indicate
by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller
reporting company. See definitions of “large accelerated filer,” “accelerated filer,” and “smaller
reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer
|
|
[ ]
|
|
Accelerated filer
|
|
[ ]
|
|
|
|
|
|
|
Non-accelerated
filer
|
|
[ ] (Do
not check if a smaller reporting company)
|
|
Smaller reporting company
|
|
[X]
|
|
|
|
|
Emerging growth company
|
|
[X]
|
|
|
|
|
|
|
|
|
|
|
CALCULATION
OF REGISTRATION FEE
|
|
|
|
|
|
|
|
|
|
Title
of Securities
To
Be Registered
|
|
Amount
To
Be
Registered (1)
|
|
Proposed Maximum
Offering Price
Per
Share (2)
|
|
Proposed Maximum
Aggregate
Offering Price (2)
|
|
Amount
of
Registration
Fee
|
Common
Stock, par value $0.00001 per share
|
|
200,000,000
|
|
$0.0101
|
|
$2,020,000
|
|
$244.83
|
|
(1)
|
Pursuant to Rule
416(a) under the Securities Act of 1933, this Registration Statement shall also cover any additional shares of the Registrant’s
Common Stock that become issuable under the Registrant’s 2018 Incentive Award Plan (the “Plan”) by reason
of any stock dividend, stock split, recapitalization or other similar transaction that increases the number of the outstanding
shares of the Registrant’s Common Stock.
|
(2)
|
Estimated solely
for the purpose of calculating the amount of the registration fee pursuant to Rule 45 (h) and Rule 45 (c) promulgated under
the Securities Act. The offering price per share and the aggregate offering price are based upon the average of the high
and the low price of Registrant’s common stock, as reported by OTC Markets Group Inc., on December 13, 2018.
|
PART I
Information
Required in the Section 10(a) Prospectus
The
information called for by Part I of Form S-8 is omitted from this Registration Statement in accordance with Rule 428 of the
Securities Act of 1933, as amended (the “Securities Act”) and the instructions to Form S-8. In accordance with the
rules and regulations of the Securities and Exchange Commission (the “Commission”) and the instructions to Form S-8,
such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus
supplements pursuant to Rule 424.
PART
II
Information
Required in the Registration Statement
Item 3.
|
Incorporation
of Documents by Reference
.
|
The
following documents filed by the Registrant with the Commission pursuant to the Securities Exchange Act of 1934 (the “Exchange
Act”), are incorporated herein by reference:
|
(a)
|
the
Registrant’s Annual Report on Form 10-K for the year ended December 31, 2017, filed on April 2, 2018 which contains
audited financial statements for the Registrant’s latest fiscal year; and
|
|
(b)
|
All
other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by
the Registrant’s Annual Report referred to in (a) above.
|
All
documents that the Registrant subsequently files pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to
the filing of a post-effective amendment hereto which indicates that all of the shares of common stock offered have been sold
or which deregisters all of such shares then remaining unsold, shall be deemed to be incorporated by reference herein and to be
a part hereof from the date of the filing of such documents; except as to any portion of any future annual or quarterly report
to shareholders or document or current report furnished under current Items 2.02 or 7.01 of Form 8-K, and exhibits furnished on
such form that relate to such items, that is not deemed filed under such provisions. For purposes hereof, any statement contained
in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded to the
extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated
by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except
as so modified or superseded, to constitute a part hereof.
No information
filed under Item 2.02 or Item 7.01 of any Current Report on Form 8-K filed by the Registrant, and exhibits furnished on such Form
8-K that relate to such items, shall be deemed to be incorporated herein by reference unless such Form 8-K expressly provides
otherwise.
Item 4.
|
Description
of Securities
.
|
Common
Stock
Each
shareholder is entitled to one vote for each share of Common Stock held on all matters submitted to a vote of shareholders. Cumulative
voting for the election of directors is not authorized. Subject to preferences that may be applicable to any preferred stock outstanding
at the time, the holders of Common Stock are entitled to receive dividends out of legally available assets at such times and in
such amounts as the Registrant’s Board of Directors may from time to time determine. However, the Board does not expect
to declare dividends for the foreseeable future.
The
Common Stock is not subject to conversion or redemption and holders of Common Stock are not entitled to preemptive rights. Upon
the liquidation, dissolution or winding up of the Registrant, the remaining assets legally available for distribution to shareholders,
after payment of claims or creditors and the payment of liquidation preferences, if any, on outstanding preferred stock, will
be distributable ratably among the holders of Common Stock.
Each
share of Common Stock is entitled to one vote with respect to each matter on which shareholders are entitled to vote. Under Florida
law and the Registrant’s organizational instruments, directors are elected by plurality and the favorable vote of a majority
of the shares present at a meeting and constituting a quorum are required to act on other matters presented for shareholder action.
Florida law permits shareholders to act by written consent, which requires a majority of the votes that could be cast if the matter
consented to were presented for action at a meeting of shareholders.
Preferred
Stock
The
Registrant’s Board of Directors has power to issue up to 10,000,000 shares of preferred stock in series and to provide
for, among other things, the price, rights, preferences and privileges of each such series, which could be senior to those of
the Common Stock, without the consent of the holders of the Common Stock. Although the ability to issue preferred stock may
provide the Company with flexibility in connection with possible acquisitions and other corporate purposes, the provisions of
a series could, among other things, (a) restrict dividends paid to the holders of shares of Common Stock or grant rights
to dividends prior to those of the holders of Common Stock; (b) dilute the voting power of the holders of shares of Common
Stock or vest voting control of the Registrant in one or a few holders of a series of preferred stock; (c) impair the
liquidation rights of holders of shares of Common Stock and (d) delay or prevent a change in control of the Registrant.
The Board of Directors has not designated on authorized the issuance of any series of the preferred stock.
Warrants
and Options
The
Registrant has no warrants or options outstanding.
Item 5.
|
Interests
of Named Experts and Counsel
.
|
Barry
J. Miller, Esq., who has provided legal services to the Registrant in connection with the Plan and the preparation of this Registration
Statement, may receive shares of Common Stock as a Consultant, as defined in the Plan, for such services, as well as other services
rendered and to be rendered, but holds no shares of Common Stock on the date hereof.
tem 6.
|
Indemnification
of Directors and Officers
.
|
The
Registrant has power under the Florida Business Corporation Act (the “FBCA”) to indemnify its directors, officers,
employees and to the extent provided in such statute. Unless a determination is made by a court, the determination of whether
a director, officer or employee has acted in accordance with the applicable standard of conduct must be made by (i) a majority
vote of a quorum consisting of directors who were not parties to the proceeding or a committee consisting solely of two or more
directors who were not parties to the proceeding, (2) independent legal counsel selected by a majority vote of a quorum consisting
of directors who were not parties to the proceeding or committee of directors (or selected by the full board if a quorum or committee
cannot be obtained), or (3) the affirmative vote of the majority of a quorum consisting of the corporation’s shareholders
who were not parties to the proceeding (or by a majority vote of the corporation’s shareholders who were not parties to
the proceeding if a quorum cannot be obtained).
The
FBCA further provides that a corporation may make any other or further indemnity by resolution, bylaw, agreement, vote of shareholder
or disinterested directors or otherwise, except with respect to certain enumerated acts or omissions of such persons. Florida
law prohibits indemnification or advancement of expenses if a judgment or other final adjudication establishes that the actions
of a director, officer or employee constitute (i) a violation of criminal law, unless he had reasonable cause to believe
his conduct was lawful, (ii) a transaction from which he derived an improper personal benefit, (iii) willful misconduct
or conscious disregard for the best interests of the corporation in the case of a derivative action by a shareholder, or (iv) in
the case of a director, a circumstance under which he would be liable for an improper distribution. The FBCA does not affect a
director’s responsibilities under any other law, such as federal securities laws.
Pursuant
to the FBCA, the Registrant has provided for such indemnification under in its articles of incorporation and by-laws. The articles
of incorporation provide that Medtainer shall indemnify any director, officer, employee, or agent thereof, whether current or
former, together with his or her personal representatives, devisor heirs, in the manner and to the extent contemplated by FBCA
§607.0850, if in the judgment of a majority of the entire Board of Directors (excluding from such majority any director under
consideration for indemnification), (i) he acted in good faith and in a manner he reasonably believed to be in, or not opposed
to, the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe
his conduct was unlawful or (ii) with respect to any proceeding by, or in the right of, the corporation), if such person acted
in good faith and in a manner he or she reasonably believed to be in, or not opposed to, the best interests of the corporation
(except that no indemnification shall be made in respect of any claim, issue, or matter as to which he shall have been adjudged
to be liable unless, and only to the extent that, the court in which such proceeding was brought, or any other court of competent
jurisdiction, shall determine upon application that, despite the adjudication of liability but in view of all circumstances of
the case, he person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper.
Article
7 of the by-laws provides that the Registrant shall indemnify and reimburse and advance expenses for any director and officer,
and for any director and officer of another corporation, partnership, joint venture, trust or other enterprise serving at the
request of the Registrant, whether or not then in office, and his or her executor, administrator and heirs, and may indemnify
and reimburse and advance expenses to employees and agents of the Registrant, against all reasonable expenses actually and necessarily
incurred, including but not limited to, judgments, costs and counsel fees in connection with the defense of any litigation, civil
or administrative action, suit or proceeding, to which he may have been made a party because he is or was a director, officer,
employee or agent of Medtainer or he was serving at the request of the Registrant as a director or officer of another corporation,
partnership, joint venture, trust or other enterprise.
No pending
material litigation or proceeding involving the Registrant’s directors, executive officers, employees or other agents as
to which indemnification is being sought exists, and the Registrant is not aware of any pending or threatened material litigation
that may result in claims for indemnification by any of its directors or executive officers.
Item 7.
|
Exemption
from Registration Claimed
.
|
Not
applicable.
Exhibit No. Exhibit Description
3.1
|
Articles of Incorporation of the Registrant, filed September 5, 1997. Filed as Exhibit 3.1 to Registration Statement on Form S-1, filed on May 12, 2014 (File No 333-195866)(the “2014 Registration Statement”) and incorporated herein by reference
|
3.2
|
Amendment to Articles of Incorporation of the Registrant, filed on February 15, 1999. Filed as Exhibit 3.2 to the 2014 Registration Statement and incorporated herein by reference.
|
3.3
|
Amendment to Articles of Incorporation of the Registrant, filed on January 26, 2000. Filed as Exhibit 3.3 to the 2014 Registration Statement and incorporated herein by reference.
|
3.4
|
Amendment to Articles of Incorporation of the Registrant, filed on July 5, 2012. Filed as Exhibit 3.4 to the 2014 Registration Statement and incorporated herein by reference.
|
3.5
|
Amendment to Articles of Incorporation of the Registrant, filed on January 9, 2014. Filed as Exhibit 3.5 to the 2014 Registration Statement and incorporated herein by reference.
|
3.6
|
Amendment to Articles of Incorporation of the Registrant, filed on August 28, 2018. Filed as Exhibit 3 to the Current Report on Form 8-K of the Registrant, filed on September 21, 2018, and incorporated herein by reference.
|
3.7
|
By-laws of the Registrant. Filed as Exhibit 3.6 to the 2014 Registration Statement and incorporated herein by reference.
|
5.1
|
Opinion of Barry J. Miller, Esq. Filed herewith.
|
10.1
|
2018
Incentive Award Plan. Filed herewith.
|
10.2
|
Form
of Option Notice and Agreement. Filed herewith.
|
10.3
|
Form
of Restricted Stock Award Notice and Agreement. Filed herewith.
|
10.4
|
Form
of Restricted Unit Award Notice and Agreement. Filed herewith.
|
23.1
|
Consent of Paritz & Company, P.A. Filed herewith.
|
Item
9.
Undertakings
A. The
undersigned Registrant hereby undertakes:
1.
To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i)
To include any prospectus required by section 10(a)(3) of the Securities Act;
(ii)
To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent
post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high
end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule
424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering
price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement.
(iii)
To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement
or any material change to such information in the Registration Statement;
Provided,
however,
that paragraphs (A)(1)(i) and (A)(1)(ii) do not apply if the information required to be included in a post-effective
amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to
section 13 or section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
2.
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed
to be a new registration statement relating to the securities offered herein, and the offering of such securities at that time
shall be deemed to be the initial bona fide offering thereof.
3.
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold
at the termination of the offering.
B. The
undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing
of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable,
each filing of an employee benefit plan’s annual report pursuant to section 15(d) of the Exchange Act) that is incorporated
by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered
herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
C. Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore,
unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant
of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action,
suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered,
the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court
of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities
Act and will be governed by the final adjudication of such issue.
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it
meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on
its behalf by the undersigned, thereunto duly authorized, in the City of Corona, State of California, on this fourteenth day
of December 2018.
|
|
|
MEDTAINER, INC.
|
|
|
|
|
|
/s/
Curtis Fairbrother
|
|
|
Curtis Fairbrother
|
|
|
Chief Executive Officer
|
|
|
Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the
capacities and on the dates indicated.
|
|
|
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
/s/ Curtis
Fairbrother
Curtis
Fairbrother
|
|
Chief
Executive Officer; Director
(Principal
Executive Officer, Principal Financial Officer and Principal Accounting Officer)
|
|
December
14, 2018
|
|
|
|
/s/ Douglas
Heldoorn
Douglas
Heldoorn
|
|
Director
|
|
December
14, 2018
|
|
|
|
|
|
|
|
|